Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
Diseases
      11751 results
    
    - 
  
    
60-day prescriptions fact sheet – First Nations
This fact sheet includes information on the Pharmaceutical Benefit Scheme, 60-day prescriptions and how 60-day prescriptions can help those who are eligible. - 
  
    
The National Stillbirth Action and Implementation Plan Annual report 2, 2023
This plan provides jurisdictions with the flexibility to implement actions tailored to local contexts. - 
  
    
National Stillbirth Action and Implementation Plan - Evaluation Report 2023
The First Evaluation Report 2023 relates to the other reports published by Nous Group on the National Stillbirth Action and Implementation Plan. - 
  
    
Naloxone purple postcard for healthcare providers
Promotional postcard containing important information and details for further reading regarding the Take Home Naloxone Program. - 
  
    
Naloxone pharmacy postcard
Postcard for pharmacists regarding the THN program. Includes information about how to appropriately discuss THN with patients. - 
  
    
Naloxone available here clear sticker
A sticker that healthcare providers can display to highlight the availability of Take Home Naloxone. - 
  
    
Naloxone participation postcard
Promotional poster containing important information and details for further reading regarding the Take Home Naloxone Program. - 
  
    
Second variation for Naloxone available here sticker (pharmacy)
A sticker that healthcare providers can display to highlight the availability of Take Home Naloxone. - 
  
    
Naloxone aqua pharmacy poster
Promotional poster containing important information and details for further reading regarding the Take Home Naloxone Program. Includes wording specific for pharmacy sites. - 
  
    
Naloxone purple poster
Promotional poster containing important information and details for further reading regarding the Take Home Naloxone Program. - 
  
    
  
Take Home Naloxone program – resources
This collection contains promotional material and information for the Take Home Naloxone program. - 
  
    
Health Technology Assessment Policy and Methods Review – Reference committee meeting agenda – 6 October 2023
Health Technology Assessment Policy and Methods Review Reference Committee agenda for the 24th meeting on 6 October 2023. - 
  
    
Health Technology Assessment Policy and Methods Review - Reference committee meeting communique – 14 July 2023
The Health Technology Assessment (HTA) Policy and Methods Review (Review) Reference Committee (Committee) met by video conference on 14 July 2023.
 - 
  
    
Health Technology Assessment Policy and Methods Review - Reference committee meeting communique – 24 July 2023
The Health Technology Assessment (HTA) Policy and Methods Review (Review) Reference Committee (Committee) met by video conference on 24 July 2023. - 
  
    
Health Technology Assessment Policy and Methods Review – Reference committee meeting communique – 4 August 2023
The Health Technology Assessment (HTA) Policy and Methods Review (Review) Reference Committee (Committee) met by video conference on 4 August 2023. - 
  
    
Application Form B for Conditions other than Group 1 – Inborn Errors of Metabolism
Application for Australian Government financial assistance for individuals with Inborn Errors of Metabolism (other than DHPR, hyperphenylalaninemia and PKU). - 
  
    
Application Form A for Conditions Group 1 – Inborn Errors of Metabolism
Application for Australian Government financial assistance for individuals with Inborn Errors of Metabolism — DHPR, hyperphenylalaninemia and PKU conditions only. For other conditions, use Application Form B. - 
  
    
Application Form C – Change of details – Inborn Errors of Metabolism
Individuals registered with the Inborn Errors of Metabolism program can use this form to change their personal information. - 
  
    
Application to register as an Approved Metabolic Specialist – Inborn Errors of Metabolism
Specialist doctors can use this form to apply for registration as an approved metabolic specialist under the Inborn Errors of Metabolism (IEM) program. - 
  
    
  
National Mental Health Workforce Strategy 2022–2032
The National Mental Health Workforce Strategy 2022–2032 and associated documents provide a vision and roadmap for building a sustainable workforce that is skilled, distributed and supported to deliver mental health treatment, care and support that meets current and future population needs. - 
  
    
  
Inborn Errors of Metabolism program forms
This collection contains forms related to the Inborn Errors of Metabolism program. - 
  
    
Hearing Services Program statistics – September 2023
This document provides monthly Hearing Services Program statistics for September 2023, on clients, vouchers, devices and service providers. - 
  
    
National Women’s Health Advisory Council communique – 9 October 2023
This communique outlines the outcomes from the fourth meeting of the Council on 9 October 2023. - 
  
    
Summary of My Aged Care system changes – October 2023
This update provides a summary of changes to the My Aged Care System from 9 October 2023. - 
  
    
National Immunisation Program – Shingles program advice for vaccination providers
This fact sheet provides updated program advice for health professionals.